Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Cost-Effectiveness Analysis Of EGFR Mutation Testing And Afatinib Versus Gemcitabine-Cisplatin As First-Line Therapy For Advanced Non-Small-Cell Lung Cancer In China
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,694 | Dovepress* | 7,035+ | 816 | 7,851 | |
| PubMed Central* | 1,659 | 316 | 1,975 | ||
| Totals | 8,694 | 1,132 | 9,826 | ||
| *Since 5 December 2019 | |||||
View citations on PubMed Central and Google Scholar